Patient Summary

Lab Results Summary

Diagnosis

Primary Diagnosis: Toxic Multinodular Goitre (TMNG) with Overt Hyperthyroidism

• Massively elevated T3 and T4 with near-zero TSH = overt hyperthyroidism
• Anti-TPO is negative (21.63, well within <60) — this effectively rules out Graves' disease (autoimmune) and Hashimoto's thyroiditis as the cause
• Bilateral thyromegaly with multiple cystic/colloid nodules on ultrasound is the classic picture of multinodular goitre
• In toxic MNG, nodules become autonomous — secreting thyroid hormone independently of TSH control
• Age (56M) and pattern fits TMNG perfectly

Secondary Findings:

• Mild normocytic anaemia (Hb 11.2) — likely due to hyperthyroidism-related erythropoietic changes or concurrent nutritional deficiency
• Mild thrombocytopenia (1,22,000) — can be seen in hyperthyroidism (immune-mediated platelet destruction)
• Elevated ALP (211) — commonly elevated in hyperthyroidism due to increased bone turnover; also seen with toxic MNG
• Mildly elevated indirect bilirubin — mild haemolysis or hepatic involvement from hyperthyroidism

Treatment Plan

Step 1 — Immediate Symptom Control (Start Now)

• Propranolol 20–40 mg TID (or atenolol/metoprolol if preferred)
• Blocks peripheral effects of excess thyroid hormone — controls palpitations, tremor, heat intolerance, anxiety
• Does not reduce T3/T4 synthesis

Step 2 — Antithyroid Drug Therapy (Render Euthyroid)

• Carbimazole 20–40 mg/day (or Methimazole 15–30 mg/day) in divided doses
• Blocks iodine organification and thyroid hormone synthesis
• Takes 6–8 weeks to achieve euthyroid status
• Monitor TFTs (T3, T4, TSH) every 4–6 weeks; titrate dose accordingly
• Caution: Check CBC at baseline and if fever/sore throat develops (risk of agranulocytosis in 0.3–0.4% — reversible if caught early)
• Avoid PTU unless pregnancy (PTU associated with hepatotoxicity)

Step 3 — Definitive Therapy (After rendering euthyroid)

Step 4 — Additional Management

• Iron supplementation for mild anaemia (Hb 11.2, normocytic — check serum iron/ferritin/B12/folate to rule out concurrent deficiency)
• Monitor ALP and bone health — elevated ALP in hyperthyroidism reflects bone resorption; calcium and vitamin D supplementation advisable
• Repeat platelet count after achieving euthyroid state (thrombocytopenia often resolves with treatment)
• Follow-up MRI neck as advised by radiologist to rule out substernal extension and any suspicious nodule characteristics

Step 5 — Post-treatment (if thyroidectomy or RAI)

• Lifelong levothyroxine (LT4) replacement therapy
• Monitor TSH every 6–12 months

Investigations Still Needed

1. MRI Neck (already advised) — rule out retrosternal extension, assess nodule characteristics
2. FNAC of dominant nodule(s) — to exclude malignancy before definitive treatment
3. Free T3, Free T4 — for more precise functional assessment
4. Serum ferritin, B12, folate — work up mild anaemia
5. Bone profile (Calcium, Phosphate) — given elevated ALP and risk of thyrotoxic osteoporosis
6. ECG — to screen for atrial fibrillation (common in hyperthyroidism, especially at age 56)
7. Radioactive iodine uptake scan — if RAI therapy is being considered (patchy heterogeneous uptake expected in TMNG)

Clinical Note: The combination of markedly suppressed TSH, grossly elevated T3/T4, negative anti-TPO, and bilateral nodular goitre on ultrasound makes Toxic Multinodular Goitre the most likely diagnosis. Graves' disease is less likely given the absent antibody positivity and the nodular (not diffuse) ultrasound pattern. Prompt initiation of antithyroid therapy is essential given the degree of hormonal excess — these levels carry risk of thyroid storm, atrial fibrillation, and cardiac decompensation if untreated.

Propranolol Dosing for Mr. Mallesh

Context

• BP: 170/80 mmHg — hypertension present (likely driven by hyperthyroidism — high T3/T4 causes increased cardiac output and systemic vascular resistance)
• Patient is thin/low body weight
• Has overt hyperthyroidism (T3 >651, T4 >24, TSH <0.005)

Recommended Dose

• This is the standard starting dose per Goldman-Cecil Medicine: "20 mg every 6–8 hours, depending on severity, titrated up to maximum 240 mg/day"
• Since the patient is thin, start at the lower end — 20 mg TID (every 8 hours)
• Propranolol at this dose also reduces T3 by ~20% by inhibiting type 1 deiodinase — an added benefit

Titration

• Reassess BP and heart rate at 1 week
• Target: resting heart rate 60–80 bpm, BP <140/90
• If response is inadequate, increase to 40 mg TID (120 mg/day)
• Max dose: 240 mg/day (rarely needed for thin patients)

Why Propranolol is the Right Choice Here

• Treats both the hypertension and hyperthyroid symptoms simultaneously
• Non-selective — blocks both β1 (heart rate, BP) and β2, and inhibits T4→T3 peripheral conversion (unlike selective beta-blockers like atenolol)
• The elevated BP of 170/80 is most likely thyrotoxic hypertension — will normalise as euthyroid state is achieved with methimazole

Complete Prescription for Mr. Mallesh

• Monitor: HR and BP weekly initially; TFTs (T3, T4) at 4–6 weeks
• Caution: Do not stop propranolol abruptly; taper once euthyroid
• Once euthyroid (T3/T4 normalise in 4–6 weeks), BP will likely come down significantly — reassess need for continued antihypertensive therapy at that point

Propranolol 40 mg OD vs 40 mg BD

Standard Immediate-Release (IR) Propranolol

For Mr. Mallesh Specifically

• BP 170/80 (needs sustained control throughout the day)
• T3 >651, TSH <0.005 — overt, severe hyperthyroidism
• Thin patient (lower volume of distribution)

• Gives adequate daily dose
• Twice-daily dosing improves compliance vs TID
• 80 mg/day is also the dose at which propranolol significantly inhibits T4→T3 conversion (reduces circulating T3 by ~20%)
• For a thin patient, 40 mg BD is safer than jumping to TID

Alternative — Propranolol LA (Long-Acting)

Practical Recommendation

Propranolol 40 mg BD (morning + evening) is the most appropriate choice for this patient — adequate dose, sustained BP and HR control, twice-daily for compliance, and sufficient for T3 suppression benefit.

Carbimazole Dosing Options

For Mr. Mallesh

• Dividing into TID maintains steady suppression of thyroid peroxidase throughout the day
• More consistent blockade of T3/T4 synthesis compared to OD dosing
• Half-life of methimazole (active form) is ~6–8 hours — TID dosing aligns well

Complete Prescription Summary

Monitoring on Carbimazole

• TFTs (T3, T4) at 4–6 weeks — TSH may remain suppressed for weeks even after T3/T4 normalise, so follow T3/T4 levels
• CBC — warn patient: if fever, sore throat, or mouth ulcers develop → stop immediately and check WBC (agranulocytosis risk ~0.3%)
• Once euthyroid, reduce to maintenance dose: Carbimazole 5–10 mg OD
• Liver enzymes if jaundice/dark urine develops (cholestasis rare but possible)

Complete Treatment Plan — Mr. Mallesh (56M, Toxic MNG, BP 170/80, Thin)

CORE DRUGS + SIDE EFFECTS + COMPENSATING MEDICINES

1. Carbimazole 10 mg TID (30 mg/day)

⚠️ Written patient instruction: "If you develop fever, sore throat, or mouth ulcers — STOP carbimazole and get an urgent blood count immediately."

2. Propranolol 40 mg BD (80 mg/day)

⚠️ Never stop propranolol abruptly — taper over 1–2 weeks to avoid rebound tachycardia

3. For Mild Anaemia (Hb 11.2 g%, Normocytic)

4. For Elevated ALP (211 U/L) + Bone Protection

5. For Mild Thrombocytopenia (1,22,000 platelets)

• No specific treatment needed now
• Repeat CBC at 4 weeks
• If platelets drop below 80,000 or bleeding occurs → haematology referral

6. For Elevated Bilirubin (Total 1.2, Indirect 0.9)

• Liv 52 DS or Silymarin 140 mg BD — liver protection (especially given carbimazole cholestasis risk)
• Monitor LFTs at 6 weeks
• Will resolve with treatment of hyperthyroidism

COMPLETE PRESCRIPTION SUMMARY

FOLLOW-UP SCHEDULE

Rabeprazole + Domperidone — Rationale for This Patient

Why This Combination Works Well

Specific Benefits in This Case

Recommended Regimen

This is the standard combination tablet available in India (brands: Razo-D, Rabeloc-D, Rablet-D, etc.)

Updated Complete Prescription

One Practical Note on Domperidone

• Domperidone should be used at the lowest effective dose for shortest duration (European Medicines Agency caution — small risk of cardiac QT prolongation at high doses)
• For this patient, 10 mg BD (within the combination tablet) is safe and well within recommended limits
• If palpitations worsen, consider switching to plain Rabeprazole 20 mg OD alone once GI symptoms settle

1. Zincovit Syrup (Multivitamin + Zinc + Antioxidants)

Why Ideal for Mr. Mallesh

2. Protein Powder

Why Critical Here

• Whey protein or soy protein (if vegetarian)
• 1 scoop (25–30 g protein) OD or BD in milk or water
• Preferred brands in India: Protinex, Ensure, Nutrela, Horlicks Protein+
• Target: 1.2–1.5 g protein/kg body weight/day via diet + supplement

3. Caripill Tablet (Carica papaya leaf extract)

Why Justified for This Patient

Caripill is commonly used in India and has supportive clinical evidence particularly for thrombocytopenia — a practical and safe adjunct here.

Updated Final Prescription — Mr. Mallesh

Monitoring Summary